HPG1860

DRUG2 trials

Sponsors

Hepagene (Shanghai) Co., Ltd.

Conditions

HealthyNASH - Nonalcoholic Steatohepatitis

Phase 1

Study of Safety, Tolerability and PK, PD of HPG1860 in Healthy Subjects

CompletedNCT04480697

Hepagene (Shanghai) Co., Ltd.Healthy

Start: 2019-09-23End: 2021-08-07Updated: 2022-04-25

Phase 2

Phase 2a Study of HPG1860 in Subjects With NASH

CompletedNCT05338034

Hepagene (Shanghai) Co., Ltd.NASH - Nonalcoholic Steatohepatitis

Start: 2021-11-22End: 2023-03-28Updated: 2026-05-28